Table 3.
1 | Breast cancer .mp | 12 | ?estrogen receptor .mp |
2 | Breast neoplasm/ | 13 | 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 |
3 | Breast tumo?r* .mp | 14 | Radiogenomic* .mp |
4 | 1 or 2 or 3 | 15 | Radiomic* .mp |
5 | Ki67 antigen/ or Ki67.mp | 16 | Texture analysis .mp |
6 | Ki 67 .mp | 17 | 14 or 15 or 16 |
7 | HER2 .mp | 18 | MRI .mp |
8 | Human epidermal growth factor 2 .mp | 19 | Magnetic resonance imaging .mp |
9 | Immunohistochemistry/ | 20 | 18 or 19 |
10 | Biomarkers, tumour/ or tumo?r* biomarker* .mp | 21 | 4 and 13 and 17 and 20 |
11 | ER .mp |